pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
652
stories
Apr 28, 26
FDA claims trial 'manipulation' tainted approval of ChemoCentryx drug
endpoints
Apr 28, 26
Biotech investors gamble on M&A. Some drugmakers are betting on themselves instead.
biopharma dive
Apr 27, 26
Veradermics soars on positive data for baldness treatment
biopharma dive
Apr 27, 26
STAT+: Pharmalittle: We’re reading about a Lilly deal, an Intellia CRISPR rare-disease treatment, and more
stat
Apr 27, 26
Intellia CRISPR drug succeeds in late-stage study against rare swelling disorder
biopharma dive
Apr 27, 26
Intellia's in vivo CRISPR therapy first to succeed in Phase 3
endpoints
Apr 27, 26
STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial
stat
Apr 24, 26
Sanofi MS drug rejected in US gets an endorsement in Europe
biopharma dive
Apr 24, 26
Novartis pulls Pluvicto prostate cancer label expansion filing in the EU
endpoints
Apr 24, 26
International childhood vaccine campaign grows
stat
Apr 24, 26
STAT+: Pharmalittle: We’re reading about a Trump deal with Regeneron, reclassifying medical marijuana, and more
stat
Apr 24, 26
STAT+: Sanofi MS drug gets positive review in Europe following FDA
stat
Apr 24, 26
Sanofi’s tolebrutinib gets CHMP backing for certain MS patients despite FDA rejection
endpoints
Apr 23, 26
STAT+: Trump celebrates closing first round of drug pricing deals, promises more ahead
stat
Apr 23, 26
FDA approves Regeneron’s hearing loss gene therapy
biopharma dive
Apr 23, 26
FDA approves Regeneron's hearing loss gene therapy Otarmeni
endpoints
Apr 23, 26
STAT+: Trump’s boosting of psychedelics, cannabis signal a new era in GOP drug policy
stat
Apr 23, 26
Roche, facing biosimilar threats, puts faith in new cancer and obesity drugs
biopharma dive
Apr 22, 26
Revolution drug shows promise in early pancreatic cancer
biopharma dive
Apr 22, 26
Moderna, after losing US funding, rebounds to start mRNA bird flu vaccine trial
biopharma dive
Apr 22, 26
Merck adds to pharma’s AI push; Roche details MS drug results
biopharma dive
Dec 23, 25
Fierce Biotech Layoff Tracker 2026: Kolon cuts workforce after ph. 3 fail; Sanofi sheds 229 staffers
fiercebiotech
← prev
page 22 of 22
next →
